109 related articles for article (PubMed ID: 3486890)
1. An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.
Lynch DC; Zimmerman TS; Ling EH; Browning PJ
J Clin Invest; 1986 Jun; 77(6):2048-51. PubMed ID: 3486890
[TBL] [Abstract][Full Text] [Related]
2. Subunit composition of oligomeric human von Willebrand factor.
Lynch DC; Zimmerman TS; Kirby EP; Livingston DM
J Biol Chem; 1983 Nov; 258(21):12757-60. PubMed ID: 6605344
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.
McCarroll DR; Levin EG; Montgomery RR
J Clin Invest; 1985 Apr; 75(4):1089-95. PubMed ID: 3872883
[TBL] [Abstract][Full Text] [Related]
4. Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor.
Wagner DD; Mayadas T; Marder VJ
J Cell Biol; 1986 Apr; 102(4):1320-4. PubMed ID: 3082891
[TBL] [Abstract][Full Text] [Related]
5. Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin.
Ribes JA; Francis CW
Blood; 1990 Apr; 75(7):1460-5. PubMed ID: 2107883
[TBL] [Abstract][Full Text] [Related]
6. Multimeric composition of endothelial cell-derived von Willebrand factor.
Tsai HM; Nagel RL; Hatcher VB; Sussman II
Blood; 1989 Jun; 73(8):2074-6. PubMed ID: 2786433
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization.
Wagner DD; Marder VJ
J Cell Biol; 1984 Dec; 99(6):2123-30. PubMed ID: 6334089
[TBL] [Abstract][Full Text] [Related]
8. Sulfation of von Willebrand factor.
Carew JA; Browning PJ; Lynch DC
Blood; 1990 Dec; 76(12):2530-9. PubMed ID: 2265247
[TBL] [Abstract][Full Text] [Related]
9. Triplet structure of human von Willebrand factor.
Fischer BE; Thomas KB; Schlokat U; Dorner F
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):483-8. PubMed ID: 9531488
[TBL] [Abstract][Full Text] [Related]
10. Inducible secretion of large, biologically potent von Willebrand factor multimers.
Sporn LA; Marder VJ; Wagner DD
Cell; 1986 Jul; 46(2):185-90. PubMed ID: 3087627
[TBL] [Abstract][Full Text] [Related]
11. Disulfide bonds required to assemble functional von Willebrand factor multimers.
Dong Z; Thoma RS; Crimmins DL; McCourt DW; Tuley EA; Sadler JE
J Biol Chem; 1994 Mar; 269(9):6753-8. PubMed ID: 8120035
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin.
Fischer BE; Schlokat U; Mitterer A; Reiter M; Mundt W; Turecek PL; Schwarz HP; Dorner F
FEBS Lett; 1995 Nov; 375(3):259-62. PubMed ID: 7498512
[TBL] [Abstract][Full Text] [Related]
13. Clearance of normal and type 2A von Willebrand factor in the rat.
Stoddart JH; Andersen J; Lynch DC
Blood; 1996 Sep; 88(5):1692-9. PubMed ID: 8781425
[TBL] [Abstract][Full Text] [Related]
14. Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.
Levene RB; Booyse FM; Chediak J; Zimmerman TS; Livingston DM; Lynch DC
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6550-4. PubMed ID: 3306682
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
Dent JA; Galbusera M; Ruggeri ZM
J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
[TBL] [Abstract][Full Text] [Related]
16. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
[TBL] [Abstract][Full Text] [Related]
17. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of human von Willebrand factor.
Verweij CL
Haemostasis; 1988; 18(4-6):224-45. PubMed ID: 3069640
[TBL] [Abstract][Full Text] [Related]
19. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension.
Lopes AA; Maeda NY; Aiello VD; Ebaid M; Bydlowski SP
Chest; 1993 Nov; 104(5):1455-60. PubMed ID: 8222806
[TBL] [Abstract][Full Text] [Related]
20. Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: implication for the interpretation of satellite bands.
Hohenstein K; Griesmacher A; Weigel G; Golderer G; Ott HW
Electrophoresis; 2011 Jun; 32(13):1684-91. PubMed ID: 21647922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
